Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Silo Pharma (SILO) Interest Expenses (2019 - 2025)

Silo Pharma (SILO) has disclosed Interest Expenses for 6 consecutive years, with $32702.0 as the latest value for Q4 2025.

  • Quarterly Interest Expenses rose 11835.04% to $32702.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $37302.0 through Dec 2025, up 633.71% year-over-year, with the annual reading at $37302.0 for FY2025, 633.71% up from the prior year.
  • Interest Expenses hit $32702.0 in Q4 2025 for Silo Pharma, up from $886.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $32702.0 in Q4 2025 to a low of $47.0 in Q1 2021.
  • Historically, Interest Expenses has averaged $3061.8 across 4 years, with a median of $1079.5 in 2023.
  • Biggest five-year swings in Interest Expenses: tumbled 99.94% in 2021 and later surged 11835.04% in 2025.
  • Year by year, Interest Expenses stood at $164.0 in 2021, then surged by 66.46% to $273.0 in 2023, then increased by 0.37% to $274.0 in 2024, then soared by 11835.04% to $32702.0 in 2025.
  • Business Quant data shows Interest Expenses for SILO at $32702.0 in Q4 2025, $886.0 in Q3 2025, and $1648.0 in Q2 2025.